Phase-I Study Evaluating the Pharmacokinetic Profile of RhuDex®

NCT00532012 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

MediGene